300194.SZ
300194.SZ
CNE1000011G4
FUAN PHARM
Loading chart...

Company Profile

-

Related stocks

9989.HK
9989.HK • China
HEPALINK
4.03 HKD
752.61M USD 1Y -26.6%
603567.SS
603567.SS • China
HEILONGJIANG ZBD PHARMACEUTICAL
5.4 CNY
759.73M USD 1Y -53.4%
002793.SZ
002793.SZ • China
LUOXINPHARMACEUTICAL
4.89 CNY
795.8M USD 1Y -0.2%
300485.SZ
300485.SZ • China
SCIENCE SUN
8.57 CNY
617.67M USD 1Y -24%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%
002737.SZ
002737.SZ • China
SFPM
11.53 CNY
1.01B USD 1Y -24.8%
600195.SS
600195.SS • China
CHINA ANIMAL HUSBANDRY INDUSTRY
6.73 CNY
1.03B USD 1Y -6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
China
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
35.8% p.a.
Max Drawdown (5Y)
-43.6%
Sharpe Ratio (5Y)
-0.11
Beta Factor
0.25
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 100.8 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (35.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -72.9% in the extended horizon.
ende